China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Multimodal Imaging Fusion for the Classification and Prognostic Prediction of Breast Tumors'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136672

Registration Time: 2026/11/13

Type: Observational study

Primary Sponsor: Zhejiang Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348666

Published by HT Digital Content Services with permission from Health Daily Digest....